Biotech Business - August 11, 2021
Almi Invest invests in Strike Pharma
Almi Invest will invest just over 2 million SEK in the newly founded Uppsala-based company Strike Pharma. As previously reported by NLS, an immunotherapeutic cancer vaccine delivery-platform has been developed at the SciLifeLab Drug Discovery and Development platform (DDD). The researchers will continue to develop the method within the framework of the newly started company, […]
Uncategorized - July 21, 2021
A new Swedish immunotherapeutic cancer vaccine delivery-platform
SciLifeLab Group leader, Sara Mangsbo, Uppsala University, and her immunotherapeutic cancer vaccine delivery-platform, is now ready to leave the SciLifeLab Drug Discovery and Development platform (DDD). The immunotherapeutic cancer vaccine delivery platform is based on a new technique, called Adaptable Drug Affinity Conjugate (ADAC), that can help the immune system to detect “invisible” tumors and […]